Introduction: Influenza disease is one of the major health concerns in pediatrics. One of the most recently suggested effects of vitamin D is preventing infectious diseases. The aim of our study was to compare flu vaccine effect to flu vaccine associated to vitamin D (100,000 UI per OS) in reducing respiratory tract infections in children. Patients and Methods: 347 healthy children aged 2 to 5 years randomly selected during fall 2012 and the following season fall 2013 were included; upper and lower respiratory tract infections following vaccination were noted. Our results were analyzed using SPSS program (Chi-square and T-test). Results: Out of a total of 347 children included, 150 received flu vaccine and 197 received flu vaccine plus vitamin D. 88 children from both groups manifested upper respiratory tract infections and 64 had lower respiratory tract infections. The statistical analysis revealed no significant difference between the two groups concerning the upper respiratory tract infection (p = 0.207) and a significant difference between groups for the lower respiratory tract infection (p = 0.001). Conclusion: Coupling vitamin D to flu vaccine provides no protection against upper respiratory infections but provides an effective strategy to decrease the rate of lower respiratory infections in children 2 -5 years of age.
suggested the hypothesis that seasonal variations of serum vitamin D concentrations can affect the epidemic incidence of the flu.
On one side, vitamin D can increase the innate immune response and protect against infections of the respiratory tract, but few clinical studies have evaluated the relation between vitamin D and the seasonal flu. A clinical study has shown a decrease in the seasonal influenza infections in Japanese children receiving 1200 UI of vitamin D3 per day [2] . We have therefore decided to couple a loading dose of vitamin D (100,000 UI per OS) to the flu vaccine, and to compare the results to a group that was administered the vaccine only. We had to observe the effect of both on the incidence of the seasonal flu and upper respiratory tract infections as well as secondary lower respiratory tract infections, over 2 winter seasons from September 2012 till the end of January 2014. The 347 previously healthy children, aged 2 to 5, were randomly selected out of 3 different pediatric doctors' offices across Lebanon.
Tools and Methods
We have carried on a multi-centered, prospective study over the course up. An oral approval was documented before initiating the study. Belonging to a group or the other was performed according to a coin toss. The choice of the dose of 100,000 UI was made according to the European recommendations. Patients were followed up for 3 months only since the vaccine effect is the highest in this period. The age range of 2 to 5 years was chosen because it reflects the period of admission into collectivities, of adenoids hypertrophy and its function as a bacterial/viral reservoir. This role starts to decrease beyond 5 year of age. The exclusion of the younger than 2 years was justified by their daily supplementation. Statistical analysis of the results was executed using the SPSS (version 16.00) program (SPSS Inc., Chicago, IL); the board containing continuous and discrete variables. The discrete variables were analyzed using the Chi square method, the continuous variables using the "r" test. Probability values of p ≤ 0.05 were considered significant.
Results
The number of patients included in this study was 417, male gender was slightly more predominant (52.2%). The average age was 3.82 years with a standard deviation of 1.12. The average weight on presentation of the patients was 17.83 kg with a standard deviation of 5.16. 
Discussion
Children are a sensitive target of infection, especially at a young age and after the weaning of maternal feeding which provides important protection; Children aged 2 -5 years are most prone to infections due to their introduction to preschool/ nursery environments. However, in our study, patients who had upper respiratory tract infections had a lower average weight when compared to patients who did not have any upper respiratory tract infection.
A single Japanese study showed a decrease in the risk of children having influenza after supplementation in vitamin D. In fact, a daily dose of 1200 UI of vitamin D was administered over the course of 3 months to 50% of children aged 6 to 15, compared to a control group. The study was a double blinded, randomized, performed in the faculty of medicine at the Jikel University in Tokyo [3] .
In India, a study done on 150 children aged 2 to 5 years (similar to our group) Not dividing children into subgroups considering factors such as prematurity, socio-economic status, living area, siblings, iron deficiency anemia, gastroesophageal reflux disease that may play a role in recurrent respiratory infection might be a limitation in our study. However, our patients were healthy children and criteria of exclusion mentioned above were used.
The Other limitation can be the sample size. In addition, and serum concentrations of 25-hydroxyvitamin D would have been useful to better correlate with the results of the study.
Conclusions and Perspectives
The WHO on an international level and the State on a national level recommend flu vaccination to any person at risk, specifically young children with risk factors of infections.
The American Academy of Pediatrics and the various Pediatric societies (European, Lebanese, etc.) recommend vitamin D supplementation, in order to cover vitamin D deficiency and due to its multiple benefits.
Our study proposes to combine two beneficial molecules proved to have a synergistic effect and represents a promising strategy in public health that we are publishing in hopes of encouraging more studies and eventually promoting the use of this coupling around the world.
